サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1363292

ロボット支援内視鏡の市場規模、シェア、動向分析レポート：最終用途別、地域別、セグメント予測、2023年～2030年

Robot-assisted Endoscope Market Size, Share & Trends Analysis Report By End-use (Hospitals, Outpatient Facilities), By Region (North America, Asia Pacific, Europe, Latin America, MEA), And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 250 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
ロボット支援内視鏡の市場規模、シェア、動向分析レポート：最終用途別、地域別、セグメント予測、2023年～2030年
出版日: 2023年09月26日
発行: Grand View Research
ページ情報: 英文 250 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ロボット支援内視鏡市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のロボット支援内視鏡市場規模は、2023年から2030年にかけてCAGR 8.2％を記録し、2030年には23億6,000万米ドルに達する見込みです。

内視鏡手術を必要とする加齢に関連した医療障害は、世界の高齢化の結果、より一般的になっています。ロボット支援付き内視鏡は、高齢者に対する複雑な処置の困難を克服するのに役立ちます。外傷が少なく、入院期間が短く、回復が早いなどの利点から、低侵襲手術法はますます普及しています。外科医は、ロボット支援内視鏡の助けを借りて、より正確に、より小さな切開で複雑な治療を行うことができます。

低侵襲手術（MIS）治療の需要、米国FDAのような規制機関による新製品の承認、慢性疾患の流行などの要因が市場の成長を後押ししています。さらに、腹腔鏡機器の開発のための主なプレーヤー間のコラボレーション活動の増加が市場成長を後押ししています。例えば、2021年2月、Asensus Surgical Inc.とオランダのAmsterdam Skills Centreは、Senhance Digital Laparoscopyの2番目の欧州外科トレーニングサイトを作成するために提携しました。内視鏡手術を含む一般外科手術では、このロボットシステムの使用が推奨されています。このように、この地域の市場は、腸疾患の有病率の上昇、高齢者人口の増加、製品の進歩を続ける大手企業の存在により、予測期間中により速い速度で上昇すると予想されます。

COVID-19患者を優先し、パンデミック時の感染の危険性を低下させるため、いくつかのヘルスケア施設は選択的手術を延期しています。緊急の内視鏡治療の不足により、ロボット支援内視鏡の需要は一時的に減少しました。在院日数を短縮し、感染の危険性を低くするために、低侵襲手術法の採用が重視されるようになっています。ロボット支援内視鏡は、切開創が小さく、回復が早いという利点があるため、このような要望の変化は、その普及に好影響を与えた可能性があります。COVID-19の大流行により、最先端医療技術の価値が注目され、ヘルスケア分野における研究開発の取り組みが加速しました。ロボット支援内視鏡検査システムの改良は、このような技術革新とテクノロジーへの重点的な取り組みからもたらされた可能性があります。

さらに、ヘルスケア分野でのM&Aの増加や、その改善のための多額の投資も市場成長の原動力となっています。2022年5月、医療機器の大手メーカーであるCreo Medical Groupは、ロボット手術のリーダーであり低侵襲治療の世界的パイオニアであるIntuitiveと、Creoの手術技術と治療用ロボットシステムの互換性を促進するための長期パートナーシップ契約を締結しました。CreoのKamaptive技術とIntuitiveのロボット・プラットフォームの組み合わせにより、患者はより多くの最先端治療の選択肢を得ることになります。その一方で、内視鏡治療の高コストと有資格者の不足が市場成長の妨げになる可能性が高いです。新興国市場では、有資格者の不足とヘルスケア施設の不足が市場の課題となると思われます。

ロボット支援内視鏡市場レポートハイライト

  • 最終用途に基づくと、外来患者施設セグメントが2022年の市場シェア53.31％で市場を独占。
  • ロボットシステムは、より正確で器用に内視鏡治療を行うために採用され、患者の転帰と診断精度を向上させる。
  • 北米は2022年の収益シェア41.81%で世界市場を独占しました。
  • 米国とカナダは、ロボット支援内視鏡を含む医療機器に対する規制の枠組みを確立しており、市場への参入を促進しています。
  • ロボット内視鏡機器のFDA認可は、業界の主要プレーヤーの製品ポートフォリオ強化に好影響を生み出しています。
  • 例えば、Asensus Surgical Inc.の声明によると、2021年3月、Senhance Surgical Systemが米国でFDAの認可を受けた。このロボットシステムは、内視鏡検査やその他の一般外科手術に使用することが推奨されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場変数、動向、および範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因分析
  • 業界分析ツール
    • ポーターのファイブフォース分析
    • PESTEL分析
    • COVID-19感染症の影響分析

第4章 最終用途別ビジネス分析

  • ロボット支援内視鏡市場：最終用途別変動分析
  • 病院
  • 外来施設

第5章 地域別ビジネス分析

  • 地域別ロボット支援内視鏡市場シェア、2022年および2030年
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第6章 競合情勢

  • 企業の分類
  • 戦略マッピング
  • 企業の市況分析、2022年
  • 企業プロファイル・一覧表
    • Asensus Surgical US, Inc.
    • Intuitive Surgical
    • Auris Health, Inc.
    • Johnson &Johnson Services, Inc.
    • Brainlab AG
    • Medtronic plc.
    • Boston Scientific Corporation
    • Stryker
図表

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global Robot-assisted endoscopes market, by end-use, 2018 - 2030 (USD Million)
  • Table 4. Global Robot-assisted endoscopes market, by region, 2018 - 2030 (USD Million)
  • Table 5. North America Robot-assisted endoscopes market, by country, 2018 - 2030 (USD Million)
  • Table 6. North America Robot-assisted endoscopes market, by end-use, 2018 - 2030 (USD Million)
  • Table 7. U.S. Robot-assisted endoscopes market, by end-use, 2018 - 2030 (USD Million)
  • Table 8. Canada Robot-assisted endoscopes market, by end-use, 2018 - 2030 (USD Million)
  • Table 9. Europe Robot-assisted endoscopes market, by end-use, 2018 - 2030 (USD Million)
  • Table 10. UK Robot-assisted endoscopes market, by end-use, 2018 - 2030 (USD Million)
  • Table 11. Germany Robot-assisted endoscopes market, by end-use, 2018 - 2030 (USD Million)
  • Table 12. France Robot-assisted endoscopes market, by end-use, 2018 - 2030 (USD Million)
  • Table 13. Italy Robot-assisted endoscopes market, by end-use, 2018 - 2030 (USD Million)
  • Table 14. Spain Robot-assisted endoscopes market, by end-use, 2018 - 2030 (USD Million)
  • Table 15. Norway Robot-assisted endoscopes market, by end-use, 2018 - 2030 (USD Million)
  • Table 16. Sweden Robot-assisted endoscopes market, by end-use, 2018 - 2030 (USD Million)
  • Table 17. Denmark Robot-assisted endoscopes market, by end-use, 2018 - 2030 (USD Million)
  • Table 18. Asia Pacific Robot-assisted endoscopes market, by country, 2018 - 2030 (USD Million)
  • Table 19. Asia Pacific Robot-assisted endoscopes market, by end-use, 2018 - 2030 (USD Million)
  • Table 20. Japan Robot-assisted endoscopes market, by end-use, 2018 - 2030 (USD Million)
  • Table 21. China Robot-assisted endoscopes market, by end-use, 2018 - 2030 (USD Million)
  • Table 22. India Robot-assisted endoscopes market, by end-use, 2018 - 2030 (USD Million)
  • Table 23. Australia Robot-assisted endoscopes market, by end-use, 2018 - 2030 (USD Million)
  • Table 24. South Korea Robot-assisted endoscopes market, by end-use, 2018 - 2030 (USD Million)
  • Table 25. Thailand Robot-assisted endoscopes market, by end-use, 2018 - 2030 (USD Million)
  • Table 26. Latin America Robot-assisted endoscopes market, by country, 2018 - 2030 (USD Million)
  • Table 27. Latin America Robot-assisted endoscopes market, by end-use, 2018 - 2030 (USD Million)
  • Table 28. Brazil Robot-assisted endoscopes market, by end-use, 2018 - 2030 (USD Million)
  • Table 29. Mexico Robot-assisted endoscopes market, by end-use, 2018 - 2030 (USD Million)
  • Table 30. Argentina Robot-assisted endoscopes market, by end-use, 2018 - 2030 (USD Million)
  • Table 31. Colombia Robot-assisted endoscopes market, by end-use, 2018 - 2030 (USD Million)
  • Table 32. Middle East & Africa Robot-assisted endoscopes market, by country, 2018 - 2030 (USD Million)
  • Table 33. Middle East & Africa Robot-assisted endoscopes market, by end-use, 2018 - 2030 (USD Million)
  • Table 34. South Africa Robot-assisted endoscopes market, by end-use, 2018 - 2030 (USD Million)
  • Table 35. Saudi Arabia Robot-assisted endoscopes market, by end-use, 2018 - 2030 (USD Million)
  • Table 36. UAE Robot-assisted endoscopes market, by end-use, 2018 - 2030 (USD Million)
  • Table 37. Kuwait Robot-assisted endoscopes market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig 1. Market research process
  • Fig 2. Information procurement
  • Fig 3. Primary research pattern
  • Fig 4. Market research approaches
  • Fig 5. Value chain-based sizing & forecasting
  • Fig 6. Market formulation & validation
  • Fig 7. Robot-assisted endoscopes market segmentation
  • Fig 8. Market snapshot, 2022
  • Fig 9. Segment snapshot
  • Fig 10. Competitive landscape snapshot
  • Fig 11. Market trends & outlook
  • Fig 12. Market driver relevance analysis (current & future impact)
  • Fig 13. Market restraint relevance analysis (current & future impact)
  • Fig 14. PESTLE analysis
  • Fig 15. Porter's five forces analysis
  • Fig 16. Robot-assisted endoscopes market: End-use outlook and key takeaways
  • Fig 17. Robot-assisted endoscopes market: End-use movement analysis
  • Fig 18. Hospitals market revenue, 2018 - 2030 (USD Million)
  • Fig 19. Outpatient facilities market revenue, 2018 - 2030 (USD Million)
  • Fig 20. Regional marketplace: key takeaways
  • Fig 21. Regional outlook, 2022 & 2030
  • Fig 22. Robot-assisted endoscopes market: Region movement analysis
  • Fig 23. North America Robot-assisted endoscopes market, 2018 - 2030 (USD Million)
  • Fig 24. U.S. country dynamics
  • Fig 25. U.S. Robot-assisted endoscopes market, 2018 - 2030 (USD Million)
  • Fig 26. Canada country dynamics
  • Fig 27. Canada Robot-assisted endoscopes market, 2018 - 2030 (USD Million)
  • Fig 28. Europe Robot-assisted endoscopes market, 2018 - 2030 (USD Million)
  • Fig 29. Germany country dynamics
  • Fig 30. Germany Robot-assisted endoscopes market, 2018 - 2030 (USD Million)
  • Fig 31. UK country dynamics
  • Fig 32. UK Robot-assisted endoscopes market, 2018 - 2030 (USD Million)
  • Fig 33. France country dynamics
  • Fig 34. France Robot-assisted endoscopes Market, 2018 - 2030 (USD Million)
  • Fig 35. Italy country dynamics
  • Fig 36. Italy Robot-assisted endoscopes market, 2018 - 2030 (USD Million)
  • Fig 37. Spain country dynamics
  • Fig 38. Spain Robot-assisted endoscopes Market, 2018 - 2030 (USD Million)
  • Fig 39. Sweden country dynamics
  • Fig 40. Sweden Robot-assisted endoscopes Market, 2018 - 2030 (USD Million)
  • Fig 41. Norway country dynamics
  • Fig 42. Norway Robot-assisted endoscopes market, 2018 - 2030 (USD Million)
  • Fig 43. Denmark country dynamics
  • Fig 44. Denmark Robot-assisted endoscopes market, 2018 - 2030 (USD Million)
  • Fig 45. Asia Pacific Robot-assisted endoscopes market, 2018 - 2030 (USD Million)
  • Fig 46. Japan country dynamics
  • Fig 47. Japan Robot-assisted endoscopes Market, 2018 - 2030 (USD Million)
  • Fig 48. China country dynamics
  • Fig 49. China Robot-assisted endoscopes market, 2018 - 2030 (USD Million)
  • Fig 50. India country dynamics
  • Fig 51. India Robot-assisted endoscopes market, 2018 - 2030 (USD Million)
  • Fig 52. Australia country dynamics
  • Fig 53. Australia Robot-assisted endoscopes market, 2018 - 2030 (USD Million)
  • Fig 54. South Korea country dynamics
  • Fig 55. South Korea Robot-assisted endoscopes market, 2018 - 2030 (USD Million)
  • Fig 56. Thailand country dynamics
  • Fig 57. Thailand Robot-assisted endoscopes market, 2018 - 2030 (USD Million)
  • Fig 58. Latin America RFID in Pharmaceuticals market, 2018 - 2030 (USD Million)
  • Fig 59. Brazil country dynamics
  • Fig 60. Brazil Robot-assisted endoscopes market, 2018 - 2030 (USD Million)
  • Fig 61. Mexico country dynamics
  • Fig 62. Mexico Robot-assisted endoscopes market, 2018 - 2030 (USD Million)
  • Fig 63. Argentina country dynamics
  • Fig 64. Argentina Robot-assisted endoscopes market, 2018 - 2030 (USD Million)
  • Fig 65. Colombia country dynamics
  • Fig 66. Colombia Robot-assisted endoscopes market, 2018 - 2030 (USD Million)
  • Fig 67. Middle East and Africa Robot-assisted endoscopes market, 2018 - 2030 (USD Million)
  • Fig 68. South Africa country dynamics
  • Fig 69. South Africa Robot-assisted endoscopes market, 2018 - 2030 (USD Million)
  • Fig 70. Saudi Arabia country dynamics
  • Fig 71. Saudi Arabia Robot-assisted endoscopes market, 2018 - 2030 (USD Million)
  • Fig 72. UAE country dynamics
  • Fig 73. UAE Robot-assisted endoscopes market, 2018 - 2030 (USD Million)
  • Fig 74. Kuwait country dynamics
  • Fig 75. Kuwait Robot-assisted endoscopes market, 2018 - 2030 (USD Million)
  • Fig 76. Company categorization
  • Fig 77. Strategy mapping
  • Fig 78. Company market position analysis
目次
Product Code: GVR-4-68040-127-5

Robot-assisted Endoscope Market Growth & Trends:

The global robot-assisted endoscope market size is expected to reach USD 2.36 billion by 2030, registering a CAGR of 8.2% from 2023 to 2030, according to a new report by Grand View Research, Inc.. Age-related medical disorders requiring endoscopic operations are more prevalent as a result of the world's aging population. Endoscopes with robotic assistance assist in overcoming the difficulties of complex procedures on elderly people. Due to their advantages, such as less trauma, shorter hospital stays, and quicker recovery times, minimally invasive surgical methods have become increasingly popular. Surgeons can carry out intricate treatments with more precision and through smaller incisions with the help of robot-assisted endoscopes.

Factors, such as the demand for minimally invasive surgical (MIS) treatments, new product approvals by regulatory bodies like the U.S. FDA, and the prevalence of chronic illnesses are boosting the market growth. Moreover, the increasing collaboration activities among key players for the development of laparoscopy instruments drive market growth. For instance, in February 2021, Asensus Surgical Inc. and the Amsterdam Skills Centre, Netherlands partnered to create a second European Surgical Training Site for Senhance Digital Laparoscopy. The use of this robotic system in general surgery, including endoscopic operations, is recommended. Thus, it is anticipated that the market in this region will rise at a faster rate during the projected period as a result of the rising prevalence of bowel disorders, the growing elderly population, and the presence of major players with ongoing product advancements.

To prioritize COVID-19 patients and lower the danger of transmission during the pandemic, several healthcare facilities put off elective operations. The lack of urgent endoscopic treatments temporarily decreased the demand for robot-assisted endoscopes. To shorten hospital stays and lower the danger of infection, there was a growing emphasis on adopting minimally invasive surgical methods. As robot-assisted endoscopes provide advantages in terms of smaller incisions and quicker recovery times, this shift in desire may have had a favorable impact on their uptake. The COVID-19 pandemic raised attention to the value of cutting-edge medical technologies and sped up research and development initiatives within the healthcare sector. System improvements for robot-assisted endoscopy may have resulted from this greater emphasis on innovation and technology.

In addition, the market growth is driven by an increase in the number of mergers & acquisitions in the healthcare sector as well as significant investments for its improvement. In May 2022, Creo Medical Group, a significant manufacturer of medical devices, signed a long-term partnership agreement with Intuitive, a leader in robotic surgery and a global pioneer in less-invasive care, to promote compatibility among Creo surgery technology and therapeutic robotic systems. Patients will have more state-of-the-art treatment options due to the combination of Creo's Kamaptive technology and Intuitive's robotic platform. On the other hand, the market growth is likely to be hampered by the high cost of endoscopic treatments and a shortage of qualified personnel. The market will be challenged by a scarcity of qualified workers and a lack of healthcare facilities in developing nations.

Robot-assisted Endoscope Market Report Highlights:

  • Based on the end-use, the outpatient facilities segment dominated the market with a market share of 53.31% in 2022
  • Robotic systems are employed to perform endoscopic treatments with more accuracy and dexterity, improving patient outcomes and diagnostic precision
  • North America dominated the global market with a revenue share of 41.81% of the revenue share in 2022
  • Both the United States and Canada have established regulatory frameworks for medical devices, including robot-assisted endoscopes, which have facilitated their entry into the market
  • The FDA clearance of the robotic endoscopy devices creates a positive impact on enhancing the product portfolio for the industry's key players
  • For instance, in March 2021, the Senhance Surgical System was approved by the FDA in the U.S., according to a statement from Asensus Surgical Inc. It was advised to use this robotic system for endoscopy and other general surgery procedures

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Information Procurement
  • 1.2. Information or Data Analysis
  • 1.3. Market Scope & Segment Definition
  • 1.4. Market Model
    • 1.4.1. Market Study, By Company Market Share
    • 1.4.2. Regional Analysis

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing incidence of chronic disease
      • 3.2.1.2. Technological advancements of robot-assisted endoscopes
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of endoscopic systems
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. End-use Business Analysis

  • 4.1. Robot-Assisted Endoscopes Market: End-use Movement Analysis
  • 4.2. Hospitals
    • 4.2.1. Hospitals Market, 2018 - 2030 (USD Million)
  • 4.3. Outpatient Facilities
    • 4.3.1. Outpatient Facilities Market, 2018 - 2030 (USD Million)

Chapter 5. Regional Business Analysis

  • 5.1. Robot-Assisted Endoscopes Market Share By Region, 2022 & 2030
  • 5.2. North America
    • 5.2.1. SWOT Analysis
    • 5.2.2. North America Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
    • 5.2.3. U.S.
      • 5.2.3.1. Key Country Dynamics
      • 5.2.3.2. Target Disease Prevalence
      • 5.2.3.3. Competitive Scenario
      • 5.2.3.4. Regulatory Framework
      • 5.2.3.5. U.S. Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
    • 5.2.4. Canada
      • 5.2.4.1. Key Country Dynamics
      • 5.2.4.2. Target Disease Prevalence
      • 5.2.4.3. Competitive Scenario
      • 5.2.4.4. Regulatory Framework
      • 5.2.4.5. Canada Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
  • 5.3. Europe
    • 5.3.1. SWOT Analysis
    • 5.3.2. Europe Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
    • 5.3.3. UK
      • 5.3.3.1. Key Country Dynamics
      • 5.3.3.2. Target Disease Prevalence
      • 5.3.3.3. Competitive Scenario
      • 5.3.3.4. Regulatory Framework
      • 5.3.3.5. UK Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
    • 5.3.4. Germany
      • 5.3.4.1. Key Country Dynamics
      • 5.3.4.2. Target Disease Prevalence
      • 5.3.4.3. Competitive Scenario
      • 5.3.4.4. Regulatory Framework
      • 5.3.4.5. Germany Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
    • 5.3.5. France
      • 5.3.5.1. Key Country Dynamics
      • 5.3.5.2. Target Disease Prevalence
      • 5.3.5.3. Competitive Scenario
      • 5.3.5.4. Regulatory Framework
      • 5.3.5.5. France Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
    • 5.3.6. Italy
      • 5.3.6.1. Key Country Dynamics
      • 5.3.6.2. Target Disease Prevalence
      • 5.3.6.3. Competitive Scenario
      • 5.3.6.4. Regulatory Framework
      • 5.3.6.5. Italy Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
    • 5.3.7. Spain
      • 5.3.7.1. Key Country Dynamics
      • 5.3.7.2. Target Disease Prevalence
      • 5.3.7.3. Competitive Scenario
      • 5.3.7.4. Regulatory Framework
      • 5.3.7.5. Spain Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
    • 5.3.8. Denmark
      • 5.3.8.1. Key Country Dynamics
      • 5.3.8.2. Target Disease Prevalence
      • 5.3.8.3. Competitive Scenario
      • 5.3.8.4. Regulatory Framework
      • 5.3.8.5. Denmark Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
    • 5.3.9. Sweden
      • 5.3.9.1. Key Country Dynamics
      • 5.3.9.2. Target Disease Prevalence
      • 5.3.9.3. Competitive Scenario
      • 5.3.9.4. Regulatory Framework
      • 5.3.9.5. Sweden Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
    • 5.3.10. Norway
      • 5.3.10.1. Key Country Dynamics
      • 5.3.10.2. Target Disease Prevalence
      • 5.3.10.3. Competitive Scenario
      • 5.3.10.4. Regulatory Framework
      • 5.3.10.5. Norway Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
  • 5.4. Asia Pacific
    • 5.4.1. SWOT Analysis
    • 5.4.2. Asia Pacific Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
    • 5.4.3. Japan
      • 5.4.3.1. Key Country Dynamics
      • 5.4.3.2. Target Disease Prevalence
      • 5.4.3.3. Competitive Scenario
      • 5.4.3.4. Regulatory Framework
      • 5.4.3.5. Japan Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
    • 5.4.4. China
      • 5.4.4.1. Key Country Dynamics
      • 5.4.4.2. Target Disease Prevalence
      • 5.4.4.3. Competitive Scenario
      • 5.4.4.4. Regulatory Framework
      • 5.4.4.5. China Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
    • 5.4.5. India
      • 5.4.5.1. Key Country Dynamics
      • 5.4.5.2. Target Disease Prevalence
      • 5.4.5.3. Competitive Scenario
      • 5.4.5.4. Regulatory Framework
      • 5.4.5.5. India Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
    • 5.4.6. Australia
      • 5.4.6.1. Key Country Dynamics
      • 5.4.6.2. Target Disease Prevalence
      • 5.4.6.3. Competitive Scenario
      • 5.4.6.4. Regulatory Framework
      • 5.4.6.5. Australia Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
    • 5.4.7. Thailand
      • 5.4.7.1. Key Country Dynamics
      • 5.4.7.2. Target Disease Prevalence
      • 5.4.7.3. Competitive Scenario
      • 5.4.7.4. Regulatory Framework
      • 5.4.7.5. Thailand Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
    • 5.4.8. South Korea
      • 5.4.8.1. Key Country Dynamics
      • 5.4.8.2. Target Disease Prevalence
      • 5.4.8.3. Competitive Scenario
      • 5.4.8.4. Regulatory Framework
      • 5.4.8.5. South Korea Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
  • 5.5. Latin America
    • 5.5.1. SWOT Analysis
    • 5.5.2. Latin America Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
    • 5.5.3. Brazil
      • 5.5.3.1. Key Country Dynamics
      • 5.5.3.2. Target Disease Prevalence
      • 5.5.3.3. Competitive Scenario
      • 5.5.3.4. Regulatory Framework
      • 5.5.3.5. Brazil Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
    • 5.5.4. Mexico
      • 5.5.4.1. Key Country Dynamics
      • 5.5.4.2. Target Disease Prevalence
      • 5.5.4.3. Competitive Scenario
      • 5.5.4.4. Regulatory Framework
      • 5.5.4.5. Mexico Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
    • 5.5.5. Argentina
      • 5.5.5.1. Key Country Dynamics
      • 5.5.5.2. Target Disease Prevalence
      • 5.5.5.3. Competitive Scenario
      • 5.5.5.4. Regulatory Framework
      • 5.5.5.5. Argentina Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
  • 5.6. MEA
    • 5.6.1. SWOT Analysis
    • 5.6.2. MEA Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
    • 5.6.3. South Africa
      • 5.6.3.1. Key Country Dynamics
      • 5.6.3.2. Target Disease Prevalence
      • 5.6.3.3. Competitive Scenario
      • 5.6.3.4. Regulatory Framework
      • 5.6.3.5. South Africa Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
    • 5.6.4. Saudi Arabia
      • 5.6.4.1. Key Country Dynamics
      • 5.6.4.2. Target Disease Prevalence
      • 5.6.4.3. Competitive Scenario
      • 5.6.4.4. Regulatory Framework
      • 5.6.4.5. Saudi Arabia Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
    • 5.6.5. UAE
      • 5.6.5.1. Key Country Dynamics
      • 5.6.5.2. Target Disease Prevalence
      • 5.6.5.3. Competitive Scenario
      • 5.6.5.4. Regulatory Framework
      • 5.6.5.5. UAE Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
    • 5.6.6. Kuwait
      • 5.6.6.1. Key Country Dynamics
      • 5.6.6.2. Target Disease Prevalence
      • 5.6.6.3. Competitive Scenario
      • 5.6.6.4. Regulatory Framework
      • 5.6.6.5. Kuwait Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Company Categorization
  • 6.2. Strategy Mapping
  • 6.3. Company Market Position Analysis, 2022
  • 6.4. Company Profiles/Listing
    • 6.4.1. Asensus Surgical US, Inc.
      • 6.4.1.1. Overview
      • 6.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.1.3. Product Benchmarking
      • 6.4.1.4. Strategic Initiatives
    • 6.4.2. Intuitive Surgical
      • 6.4.2.1. Overview
      • 6.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.2.3. Product Benchmarking
      • 6.4.2.4. Strategic Initiatives
    • 6.4.3. Auris Health, Inc.
      • 6.4.3.1. Overview
      • 6.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.3.3. Product Benchmarking
      • 6.4.3.4. Strategic Initiatives
    • 6.4.4. Johnson & Johnson Services, Inc.
      • 6.4.4.1. Overview
      • 6.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.4.3. Product Benchmarking
      • 6.4.4.4. Strategic Initiatives
    • 6.4.5. Brainlab AG
      • 6.4.5.1. Overview
      • 6.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.5.3. Product Benchmarking
      • 6.4.5.4. Strategic Initiatives
    • 6.4.6. Medtronic plc.
      • 6.4.6.1. Overview
      • 6.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.6.3. Product Benchmarking
      • 6.4.6.4. Strategic Initiatives
    • 6.4.7. Boston Scientific Corporation
      • 6.4.7.1. Overview
      • 6.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.7.3. Product Benchmarking
      • 6.4.7.4. Strategic Initiatives
    • 6.4.8. Stryker
      • 6.4.8.1. Overview
      • 6.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.8.3. Product Benchmarking
      • 6.4.8.4. Strategic Initiatives